Skip to content

Evaluation of the clinical practice effects of thoracic surgery assisted by Artificial Intelligence-based virtual 3D reconstruction

Evaluation of the clinical practice effects of thoracic surgery assisted by Artificial Intelligence-based virtual 3D reconstruction: A prospective, multicenter, multiple readers multiple cases (MRMC), paired design clinical trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083950
Enrollment
Unknown
Registered
2024-05-08
Start date
2024-05-10
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Intervention group:Doctors may use preoperative chest CT images and AI 3D reconstruction
Control group:Doctors may use preoperative chest CT images, but not AI 3D reconstruction

Sponsors

Peking university cancer hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age 18 and above The tumor is confined to one lobe of the lung The surgical options were lobectomy or pulmonary segmentectomy Written informed consent

Exclusion criteria

Exclusion criteria: Refused to participate in the study, refused to sign an informed consent form The patient had purchased other 3D reconstruction software products and services commercially by himself, which did not conform to the principle of randomization. The surgical options were wedge resection or combined lobectomy. History of tuberculosis, thoracic surgery, and a history of radiotherapy for breast cancer can lead to the formation of thoracic adhesions.

Design outcomes

Primary

MeasureTime frame
Operation time;

Secondary

MeasureTime frame
Intra-operation blood loss;Time elapsed since specimen removal. ;Change in surgical approach.;Accuracy of preoperative delineation by the physician: ;Length of hospital stay;post-operative complications;Duration of postoperative drainage tube placement;Total drainage volume;Readmission rate;Emergency room readmission rate;Perioperative mortality;

Countries

China

Contacts

Public ContactNan Wu

Peking university cancer hospital

nanwu@bjmu.edu.cn+86 139 1015 4426

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026